NCT06780163View on ClinicalTrials.gov

Effect of Vaginal Estrogen on Alterations in the Urine Microbiome of Menopausal Women With Overactive Bladder

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Overactive Bladder (OAB)MenopauseMicrobiome
Interventions
DRUG

17β-estradiol 10 mcg

17β-estradiol 10 mcg will be given to all participants. The participants will be asked to use 1 tab daily for 2 weeks vaginally before bed, then 1 tab twice a week vaginally before bed until 12 weeks

Trial Locations (1)

10400

Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok

All Listed Sponsors
lead

Mahidol University

OTHER